Paired Ends

Premium

Allan Bombard has become chief medical officer of Sequenom, a new position, the company said this week. He will oversee Sequenom’s clinical and medical affairs, including clinical strategy, operations, and clinical advocacy.

Prior to joining Sequenom, Bombard was CEO of Lenetix Medical Laboratory. He holds an MD from the George Washington University School of Medicine and Health Sciences, an MBA from the University of San Diego, and a BA from Colgate University.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.